Asthma Endotypes
Cross-source consensus on Asthma Endotypes from 1 sources and 6 claims.
1 sources · 6 claims
How it works
Evidence quality
Other
Highlighted claims
- The protocol defines type 2 high asthma using asthma diagnosis plus FeNO, blood eosinophil, or tissue eosinophilia criteria. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
- Likely type 2 low asthma is defined using low FeNO, low blood eosinophils, and no available airway eosinophilia. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
- Asthma is treated in the article as a heterogeneous disease with type 2 high and type 2 low inflammatory endotypes. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
- Type 2 high asthma may be identified clinically by elevated eosinophils or fractional exhaled nitric oxide. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
- Type 2 low asthma has low or absent type 2 biomarkers and may involve neutrophilic immune responses. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study
- The likely type 2 low group may include some participants with lower-level type 2 inflammation. — Real-world and Genomic data-based Asthma Insights through Network Analysis (REGAIN study): protocol for a novel retrospective and prospective longitudinal asthma cohort study